| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.45 | 0.1 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.43 | 5e-05 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.4 | 0.0005 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.32 | 0.002 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-12 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-12 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-07 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-10 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-11 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-11 |